Cargando…

Pharmacodynamics of rituximab on B lymphocytes in paediatric patients with autoimmune diseases

AIMS: Rituximab is a chimeric IgG‐1 monoclonal antibody that depletes B cells, aiding in the treatment of several conditions including autoimmune diseases. It is not licensed for use in children. This study aimed to quantify the B cell‐related pharmacodynamics of rituximab in children with autoimmun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Shan, Yu, Huixin, Surti, Ayesha, Cheng, Iek, Marks, Stephen D., Brogan, Paul A., Eleftheriou, Despina, Standing, Joseph F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6624401/ https://www.ncbi.nlm.nih.gov/pubmed/31026092 http://dx.doi.org/10.1111/bcp.13970

Ejemplares similares

Retrospective case series describing the efficacy, safety and cost-effectiveness of a vial-sharing programme for canakinumab treatment for paediatric patients with cryopyrin-associated periodic syndrome
por: Elmi, Abdulkadir A., et al.
Publicado: (2019)

Population Pharmacodynamic Modelling of the CD19+ Suppression Effects of Rituximab in Paediatric Patients with Neurological and Autoimmune Diseases
por: Riva, Natalia, et al.
Publicado: (2023)

Use of rituximab in paediatric nephrology
por: Sinha, Rajiv, et al.
Publicado: (2021)

Paediatric Behçet’s disease: a UK tertiary centre experience
por: Nanthapisal, Sira, et al.
Publicado: (2016)

Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunology()
por: Barker, Charlotte I.S., et al.
Publicado: (2014)

Successful use of ofatumumab in two cases of early-onset juvenile SLE with thrombocytopenia caused by a mutation in protein kinase C δ
por: Lei, Linda, et al.
Publicado: (2018)

Preliminary validation of the paediatric vasculitis activity score (PVAS)
por: Price-Kuehne, Fiona E, et al.
Publicado: (2011)

Vasculitis update: pathogenesis and biomarkers
por: Brogan, Paul, et al.
Publicado: (2017)

Lymphocyte pharmacodynamics are not associated with autoimmunity or efficacy after alemtuzumab
por: Wiendl, Heinz, et al.
Publicado: (2019)

The Performance of Quantiferon TB Gold In-Tube as a Screening Tool in Paediatric Rheumatology prior to Initiation of Infliximab: A Single Centre's Experience
por: Maritsi, Despoina, et al.
Publicado: (2011)

Therapeutic advances in the treatment of vasculitis
por: Eleftheriou, Despina, et al.
Publicado: (2016)

Vasculitis in children
por: Eleftheriou, Despina, et al.
Publicado: (2009)

The Molecular Biology and Treatment of Systemic Vasculitis in Children
por: Eleftheriou, Despina, et al.
Publicado: (2012)

Autoinflammation due to homozygous S208 MEFV mutation
por: Hong, Ying, et al.
Publicado: (2019)

Small vessel vasculitis
por: Brogan, Paul, et al.
Publicado: (2009)

Inflammatory lesions of the orbit: a single paediatric rheumatology centre experience
por: Boulter, EL, et al.
Publicado: (2011)

SHARE – workpackage 5: evidence-based recommendations for diagnosis and treatment of rare paediatric vasculitides
por: de Graeff, Nienke, et al.
Publicado: (2014)

(99m)Tc-labeled Rituximab for Imaging B Lymphocyte Infiltration in Inflammatory Autoimmune Disease Patients
por: Malviya, G., et al.
Publicado: (2011)

Medium-size-vessel vasculitis
por: Dillon, Michael J., et al.
Publicado: (2009)

B-Lymphocyte Depletion With Rituximab and β-Cell Function: Two-Year Results
por: Pescovitz, Mark D., et al.
Publicado: (2014)

B-lymphocyte reconstitution after repeated rituximab treatment in a child with steroid-dependent autoimmune hemolytic anemia
por: van der Linde, Annelieke A.A., et al.
Publicado: (2011)

Identification of a novel monogenic autoinflammatory disease due to mutation in a mitochondrial chaperone protein in a single kindred, and cure with allogeneic haematopoietic stem cell transplantation
por: Standing, Ariane, et al.
Publicado: (2014)

Infliximab for the treatment of intravenous immunoglobulin resistant Kawasaki disease complicated by coronary artery aneurysms: a case report
por: Brogan, Robert J, et al.
Publicado: (2009)

Bayesian methods for the design and interpretation of clinical trials in very rare diseases
por: Hampson, Lisa V, et al.
Publicado: (2014)

Pharmacodynamics and cellular accumulation of amphotericin B and miltefosine in Leishmania donovani-infected primary macrophages
por: Voak, Andrew A, et al.
Publicado: (2018)

B lymphocyte-typing for prediction of clinical response to rituximab
por: Brezinschek, Hans-Peter, et al.
Publicado: (2012)

Rituximab for Autoimmune Encephalitis with Epilepsy
por: Kurukumbi, Mohankumar, et al.
Publicado: (2020)

Impaired function of endothelial progenitor cells in children with primary systemic vasculitis
por: Hong, Ying, et al.
Publicado: (2015)

Efficacy and safety of anakinra for undifferentiated autoinflammatory diseases in children: a retrospective case review
por: Garg, Suchika, et al.
Publicado: (2019)

Efficacy of rituximab in non-paraneoplastic autoimmune retinopathy
por: Boudreault, Katherine, et al.
Publicado: (2017)

Rituximab Monotherapy versus Rituximab and Bortezomib Combination Therapy for Treatment of Non-paraneoplastic Autoimmune Retinopathy
por: Maleki, Arash, et al.
Publicado: (2022)

Rituximab in Systemic Lupus Erythematosus: Transient Effects on Autoimmunity Associated Lymphocyte Phenotypes and Implications for Immunogenicity
por: Faustini, Francesca, et al.
Publicado: (2022)

Whole-Exome Sequencing Revealing Somatic NLRP3 Mosaicism in a Patient With Chronic Infantile Neurologic, Cutaneous, Articular Syndrome
por: Omoyinmi, Ebun, et al.
Publicado: (2014)

Cutaneous Vasculitis and Digital Ischaemia Caused by Heterozygous Gain-of-Function Mutation in C3
por: Omoyinmi, Ebun, et al.
Publicado: (2018)

Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis
por: Papadopoulou, Charalampia, et al.
Publicado: (2019)

Vasculitis in a patient with mevalonate kinase deficiency (MKD): a case report
por: Omoyinmi, Ebun, et al.
Publicado: (2021)

Pharmacokinetic–Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance
por: Germovsek, Eva, et al.
Publicado: (2018)

Useful pharmacodynamic endpoints in children: selection, measurement, and next steps
por: Kelly, Lauren E, et al.
Publicado: (2018)

Monogenic polyarteritis nodosa caused by ADA2 Deficiency: the GOSH experience
por: Nanthapisal, S, et al.
Publicado: (2015)

Rituximab Associated Hypogammaglobulinemia in Autoimmune Disease
por: Tieu, Joanna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3vj4ofknc4j6una053i4dm51lk